https://www.thebodypro.com/category/hiv-epidemiology/tag/conference-coverage
HIV Epidemiology

Conference Coverage

The Latest

VRC01 in HIV-Exposed Newborns: First Results Support Monthly Injections for Those at Risk Through Breastfeeding Img

VRC01 in HIV-Exposed Newborns: First Results Support Monthly Injections for Those at Risk Through Breastfeeding

Preliminary results suggest that VRC01 -- an investigational HIV neutralising monoclonal antibody -- administered subcutaneously to neonates is safe and well tolerated.

Raltegravir Pharmacokinetic Targets Met in High-Risk HIV-Exposed Infants Img

Raltegravir Pharmacokinetic Targets Met in High-Risk HIV-Exposed Infants

Daily raltegravir was safe and well tolerated at six weeks of life and met pharmacokinetic targets in HIV-exposed infants, according to data presented at CROI 2017.

Tenofovir Alafenamide Exposure Is Modestly Higher in Children Than Adults Img

Tenofovir Alafenamide Exposure Is Modestly Higher in Children Than Adults

Tenofovir alafenamide (TAF) and its metabolite tenofovir (TFV) exposures are slightly higher in children aged 6-12 years compared with adults.

World Health Organization Pediatric Dosing Tool Img

World Health Organization Pediatric Dosing Tool

A pediatric dosing tool developed by the World Health Organization might assist in the design of clinical trials for dosing in children.

Harnessing Vaginal Microbiota to Protect Women From HIV: What We Know and Don't Know Img

Harnessing Vaginal Microbiota to Protect Women From HIV: What We Know and Don't Know

If you're a provider, you want to offer patients the latest, evidence-based ways to reduce their risk for HIV -- including women who may have increased risk because of the microbes in their genital tracts.

Early Diagnosis and Treatment in Infants Is Challenging Img

Early Diagnosis and Treatment in Infants Is Challenging

"Even if we have the best drug, it cannot do anything if we don't have all [the social] aspects together," says Bindiya Meggi, M.Sc.

Communities Affected by HIV Must Have a Voice in Clinical Research Img

Communities Affected by HIV Must Have a Voice in Clinical Research

"Look for women mentors and make use of the spaces we have created for you," says Morenike Ukpong-Folayan.

Leah H. Rubin, Ph.D.

Women's HIV Status, Viral Suppression Tied to Differences in Cognitive Performance Over Time

Women with HIV tend to perform worse than HIV-negative women on cognitive performance tests, even after many years on treatment, new research finds -- but trends differed depending on the test and on women's treatment success.

Dolutegravir Pharmacokinetics, Safety and Efficacy in Young Children Img

Dolutegravir Pharmacokinetics, Safety and Efficacy in Young Children

Dolutegravir granules-in-suspension achieved satisfactory exposures in children aged between 2 and 6 years, according to data presented at CROI2017.

Estimated annual HIV infections in the U.S. declined 18%

New HIV Infections Drop 18% in 6 Years

The U.S. Centers for Disease Control and Prevention has released new data on the estimated number of annual HIV infections nationally, by transmission route and by state from 2008-2014 in the United States.